|
Dec 9
|
Income Investors Should Know That Merck & Co., Inc. (NYSE:MRK) Goes Ex-Dividend Soon
|
|
Dec 8
|
Merck's (MRK) Keytruda-Lynparza Combo Fails Lung Cancer Study
|
|
Dec 8
|
Company News for Dec 8, 2023
|
|
Dec 8
|
Merck and Eisai Provide Update on Phase 3 LEAP-001 Trial Evaluating (pembrolizumab) Plus LENVIMA® (lenvatinib) as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma
|
|
Dec 8
|
Merck suffers bad week as 3 Keytruda combination trials fail
|
|
Dec 7
|
13 Best S&P 500 Dividend Stocks To Buy
|
|
Dec 7
|
Merck Scraps Phase 3 Keytruda-Lynparza Lung Cancer Study
|
|
Dec 7
|
Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
|
|
Dec 7
|
Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
|
|
Dec 6
|
Hedge Funds are Betting on These 14 Sliding Stocks
|
|
Dec 6
|
5 Dividend Stocks That Recently Increased Their Payouts
|
|
Dec 6
|
Merck & Co., Inc.'s (NYSE:MRK) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|
|
Dec 5
|
25 States with the Lowest Life Expectancy in the US
|
|
Dec 5
|
Macroeconomic Factors Pulled Merck & Co. (MRK) in Q3
|
|
Dec 3
|
Billionaire Ken Fisher’s 10 Stock Picks with Huge Upside Potential
|
|
Dec 2
|
Merck (NYSE:MRK) Is Increasing Its Dividend To $0.77
|
|
Nov 30
|
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) for the First-Line Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer
|
|
Nov 29
|
12 Best Quality Stocks To Buy Now
|
|
Nov 29
|
AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development
|
|
Nov 29
|
Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study
|